20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development TourUnusual Whales·Jul 30 at 07:34 AMAIDX+240.00%
20/20 BioLabs to host investor webinar on East Asia business development tourPUBT·Jul 30 at 07:33 AMAIDX+240.00%
20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy | AIDX Stock NewsStockTitan·Jul 27 at 07:30 AMAIDX+240.00%
20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock | AIDX Stock NewsStockTitan·Jul 22 at 11:31 PMAIDX+240.00%
20/20 Biolabs to present OneTest webinar outlining Medicare pathway, modeling and reimbursement planTradingView·Jul 1 at 02:33 PMAIDX+240.00%
20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month | AIDX Stock NewsStockTitan·Jun 22 at 07:45 AMAIDX+240.00%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Jun 15 at 12:05 PMCYPH-808.00%GNPX0.00%
10 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jun 15 at 07:05 AMSSII-364.00%ELTX-157.00%
20/20 Biolabs Initiates Emergency Lab Testing Plans For Ebola And Hantavirus If Outbreak Arisesnasdaq·May 26 at 05:10 AMAIDX+240.00%
20/20 Biolabs: Buy Rating Reiterated on Growth Outlook and OneTest Momentum; $5 Price Target MaintainedTip Ranks·May 22 at 02:55 PMAIDX+240.00%
